Triple
T10790392
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | White Oak, Maryland |
E254561
|
entity |
| Predicate | isNearFederalFacility |
P22439
|
FINISHED |
| Object | U.S. Food and Drug Administration Office of the Chief Scientist |
E392785
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: U.S. Food and Drug Administration Office of the Chief Scientist | Statement: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Office of the Chief Scientist]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration Office of the Chief Scientist Context triple: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Office of the Chief Scientist]
-
A.
Office of the Chief Scientist
The Office of the Chief Scientist is NASA’s top scientific advisory office, responsible for providing strategic scientific guidance and ensuring the integrity and coordination of the agency’s research and exploration programs.
-
B.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
-
C.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
D.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
E.
Office of Pharmaceutical Quality
chosen
The Office of Pharmaceutical Quality is a U.S. Food and Drug Administration office responsible for ensuring the quality, safety, and consistency of human drugs throughout their lifecycle.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d6aa609f008190a294200aefcb7bd5 |
completed | April 8, 2026, 7:20 p.m. |
| NER | Named-entity recognition | batch_69d732f5b8248190a633dc44ae620a3a |
completed | April 9, 2026, 5:02 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69de562873b081908bea08c56b1c1e3f |
completed | April 14, 2026, 2:58 p.m. |
Created at: April 8, 2026, 9:17 p.m.